Suda T and Miyaura C |
[Recent advance in basic research for osteoporosis]. |
2004 |
Nippon Rinsho |
pmid:15035090
|
Matsumoto T |
[Recent advances in the regulation of bone remodeling]. |
2004 |
Nippon Rinsho |
pmid:15035093
|
Okumura S et al. |
[Regulatory mechanism of osteoclast differentiation and function]. |
2004 |
Nippon Rinsho |
pmid:15035103
|
Udagawa N et al. |
[Possible role of RANKL in bone resorption]. |
2004 |
Nippon Rinsho |
pmid:15035104
|
Okazaki T |
[PTH-related protein producing tumor]. |
2006 |
Nippon Rinsho |
pmid:17022555
|
Inoue D |
[OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)]. |
2004 |
Nippon Rinsho |
pmid:15035105
|
Suzuki Y |
[Stimulator of bone resorption interleukin-1, interleukin-6 and gp-130 cytokine family]. |
2004 |
Nippon Rinsho |
pmid:15035106
|
Chaki O |
[Osteoporosis]. |
2006 |
Nippon Rinsho |
pmid:16689336
|
Takahashi N et al. |
[Osteoprotegerin (OPG)]. |
2010 |
Nippon Rinsho |
pmid:20960766
|
Yasuda H |
[OPG, anti-rANKL antibody]. |
2005 |
Nippon Rinsho |
pmid:16164225
|
Takahashi N et al. |
[Osteoprotegerin (OPG)]. |
2005 |
Nippon Rinsho |
pmid:16149650
|
Takayanagi H |
[Cross-talk between immune and skeletal systems]. |
2002 |
Nippon Rinsho |
pmid:12510352
|
Nakamura M et al. |
[Osteoclastogenesis and bone resorption]. |
2009 |
Nippon Rinsho |
pmid:19432105
|
Masuda H and Tanaka S |
[Drugs under development for osteoporosis ]. |
2009 |
Nippon Rinsho |
pmid:19432120
|
Azuma Y |
[Animal models of osteoporosis and development of anti-osteoporotic agents]. |
2007 |
Nippon Yakurigaku Zasshi |
pmid:17878615
|
Wada T |
[RANKL inhibition in bone metastases]. |
2013 |
Nippon Yakurigaku Zasshi |
pmid:23302944
|
Kawaguchi H |
[Approach for therapeutic targets of osteoarthritis]. |
2011 |
Nippon Yakurigaku Zasshi |
pmid:21747205
|
Mori T et al. |
RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. |
2004 |
Nucleic Acids Res. |
pmid:15562003
|
Marini H et al. |
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. |
2010 |
Nutr Metab Cardiovasc Dis |
pmid:19631515
|
Huang JW et al. |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. |
2014 |
Nutr Metab Cardiovasc Dis |
pmid:24361071
|
Martin-Bautista E et al. |
Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. |
2010 |
Nutr Res |
pmid:20579524
|
Pellegrini GG et al. |
Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. |
2016 |
Nutrients |
pmid:27409635
|
Son E et al. |
Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros. |
2007 |
Nutrition |
pmid:17664058
|
Holecki M et al. |
The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. |
2007 |
Obesity (Silver Spring) |
pmid:17712108
|
Shan Y et al. |
p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. |
2010 |
Oncol. Rep. |
pmid:20204301
|
D'Amico L et al. |
Bone metastases in gastric cancer follow a RANKL-independent mechanism. |
2013 |
Oncol. Rep. |
pmid:23404437
|
Lv Z et al. |
Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. |
2014 |
Oncol. Rep. |
pmid:24337584
|
Martinetti A et al. |
Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response? |
2007 |
Oncol. Rep. |
pmid:17487415
|
Murthy RK et al. |
Bone biology and the role of the RANK ligand pathway. |
2009 |
Oncology (Williston Park, N.Y.) |
pmid:20128323
|
Pitari MR et al. |
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. |
2015 |
Oncotarget |
pmid:26160841
|
Schieferdecker A et al. |
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. |
2014 |
Oncotarget |
pmid:25138051
|
Fioramonti M et al. |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. |
2017 |
Oncotarget |
pmid:28223547
|
Katagiri T and Takahashi N |
Regulatory mechanisms of osteoblast and osteoclast differentiation. |
2002 |
Oral Dis |
pmid:12108759
|
Yamamoto T et al. |
Mechanical stress induces expression of cytokines in human periodontal ligament cells. |
2006 |
Oral Dis |
pmid:16476039
|
Yamamoto K et al. |
Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. |
2011 |
Oral Dis |
pmid:21771211
|
Park OJ et al. |
The association of osteoprotegerin gene polymorphisms with periodontitis. |
2008 |
Oral Dis |
pmid:18938269
|
Nakano M et al. |
Inhibitory effect of titanium particles on osteoclast formation generated by treatment of mouse bone marrow cells with PGE2. |
2003 |
Oral Dis |
pmid:12657033
|
Han X et al. |
Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. |
2009 |
Oral Microbiol. Immunol. |
pmid:19416447
|
Yildirim S et al. |
Human cytomegalovirus, Epstein-Barr virus and bone resorption-inducing cytokines in periapical lesions of deciduous teeth. |
2006 |
Oral Microbiol. Immunol. |
pmid:16476020
|
Garlet GP et al. |
Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. |
2006 |
Oral Microbiol. Immunol. |
pmid:16390336
|
Suda T et al. |
Regulatory roles of beta-catenin and AP-1 on osteoprotegerin production in interleukin-1alpha-stimulated periodontal ligament cells. |
2009 |
Oral Microbiol. Immunol. |
pmid:19702951
|
Fukada SY et al. |
Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases. |
2009 |
Oral Microbiol. Immunol. |
pmid:19121066
|
Nakamura H et al. |
Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo. |
2008 |
Oral Microbiol. Immunol. |
pmid:18402604
|
Lu HK et al. |
An acute injection of Porphyromonas gingivalis lipopolysaccharide modulates the OPG/RANKL system and interleukin-6 in an ovariectomized mouse model. |
2008 |
Oral Microbiol. Immunol. |
pmid:18402608
|
Kawai T et al. |
Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model. |
2007 |
Oral Microbiol. Immunol. |
pmid:17488448
|
Sandra F et al. |
Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas. |
2006 |
Oral Oncol. |
pmid:16413220
|
Martin CK et al. |
Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. |
2012 |
Oral Oncol. |
pmid:22265717
|
Lee AZ et al. |
Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative. |
2008 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:18585627
|
Menezes R et al. |
Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. |
2006 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:16920551
|
de Lange J et al. |
Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. |
2007 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:17703964
|